> Details

Hamedani, Ali G.; Chang, Angela Y.; Chen, Yineng; VanderBeek, Brian L.

Disparities in glaucoma and macular degeneration healthcare utilization among persons living with dementia in the United States

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Disparities in glaucoma and macular degeneration healthcare utilization among persons living with dementia in the United States
  • Contributor: Hamedani, Ali G.; Chang, Angela Y.; Chen, Yineng; VanderBeek, Brian L.
  • Published: Springer Science and Business Media LLC, 2024
  • Published in: Graefe's Archive for Clinical and Experimental Ophthalmology (2024)
  • Language: English
  • DOI: 10.1007/s00417-024-06573-z
  • ISSN: 0721-832X; 1435-702X
  • Origination:
  • Footnote:
  • Description: Abstract Purpose Dementia is common among patients with primary open angle glaucoma (POAG) and neovascular age-related macular degeneration (nAMD). This study compares visit frequency, diagnostic test utilization, and treatment patterns for POAG and nAMD among persons with vs. without dementia. Methods Optum’s de-identified Clinformatics® Data Mart Database (January 1, 2000-June 30, 2022) was used for this study. Two cohorts were created from newly diagnosed POAG or nAMD patients. Within each cohort, an exposure cohort was created of newly diagnosed dementia patients. The primary outcome was the number of visits to an eye care provider. Secondary analyses for the POAG cohort assessed the number of visual field tests, optical coherence tomography (OCT), and glaucoma medication prescription coverage. The secondary analysis for the nAMD cohort included the number of injections performed. Poisson regression was used to determine the relative rates of outcomes. Results POAG patients with dementia had reduced rates of eye care visits (RR 0.76, 95% CI: 0.75–0.77), lower rates of testing utilization for visual fields (RR 0.66, 95% CI: 0.63–0.68) and OCT (RR 0.67, 95% CI: 0.64–0.69), and a lower rate of glaucoma prescription medication coverage (RR 0.83, 95% CI: 0.83–0.83). nAMD patients with dementia had reduced rates of eye care visits (RR 0.74, 95% CI: 0.70–0.79) and received fewer intravitreal injections (RR 0.64, 95% CI: 0.58–0.69) than those without dementia. Conclusions POAG and nAMD patients with dementia obtained less eye care and less monitoring and treatment of their disease. These findings suggest that this population may be vulnerable to gaps in ophthalmic care.